CDKN2B and melanoma: CDKN2B‐AS1 rs1011970 was reported as a risk variant for melanoma and correlated with reduced expression of CDKN2B‐AS1,33 whereas rs11515 polymorphism was connected to breast cancer and elevated expression of CDKN2B‐AS1.34